Inhibition of Histone Deacetylase 3 Causes Replication Stress in Cutaneous T Cell Lymphoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Histone Deacetylase 3 Causes Replication Stress in Cutaneous T Cell Lymphoma
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 7, Pages e68915
Publisher
Public Library of Science (PLoS)
Online
2013-07-23
DOI
10.1371/journal.pone.0068915
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cutaneous T cell lymphoma: update on treatment
- (2012) Uwe Wollina INTERNATIONAL JOURNAL OF DERMATOLOGY
- Monitoring the spatiotemporal dynamics of proteins at replication forks and in assembled chromatin using isolation of proteins on nascent DNA
- (2012) Bianca M Sirbu et al. Nature Protocols
- Histone Deacetylase Inhibitors Globally Enhance H3/H4 Tail Acetylation Without Affecting H3 Lysine 56 Acetylation
- (2012) Paul Drogaris et al. Scientific Reports
- Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management
- (2011) Ryan A. Wilcox AMERICAN JOURNAL OF HEMATOLOGY
- The use of methotrexate in dermatology: a review
- (2011) Sarah Shen et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Analysis of protein dynamics at active, stalled, and collapsed replication forks
- (2011) B. M. Sirbu et al. GENES & DEVELOPMENT
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- HDAC3 Is a Critical Negative Regulator of Long-Term Memory Formation
- (2011) S. C. McQuown et al. JOURNAL OF NEUROSCIENCE
- Hdac3 Is Essential for the Maintenance of Chromatin Structure and Genome Stability
- (2010) Srividya Bhaskara et al. CANCER CELL
- Inhibition of Histone Deacetylase in Cancer Cells Slows Down Replication Forks, Activates Dormant Origins, and Induces DNA Damage
- (2010) Chiara Conti et al. CANCER RESEARCH
- Epigenetic therapy of lymphoma using histone deacetylase inhibitors
- (2010) Maribel Cotto et al. Clinical & Translational Oncology
- Current and Emerging Treatment Strategies for Cutaneous T-cell Lymphoma
- (2010) Frederick Lansigan et al. DRUGS
- Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression
- (2010) T. Yamaguchi et al. GENES & DEVELOPMENT
- Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
- (2010) Sean J. Whittaker et al. JOURNAL OF CLINICAL ONCOLOGY
- Two New Pimelic Diphenylamide HDAC Inhibitors Induce Sustained Frataxin Upregulation in Cells from Friedreich's Ataxia Patients and in a Mouse Model
- (2010) Myriam Rai et al. PLoS One
- The impact of heterochromatin on DSB repair
- (2009) Aaron A. Goodarzi et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Bexarotene therapy for mycosis fungoides and Sézary syndrome
- (2009) R.A. Abbott et al. BRITISH JOURNAL OF DERMATOLOGY
- Chemical Probes Identify a Role for Histone Deacetylase 3 in Friedreich's Ataxia Gene Silencing
- (2009) Chunping Xu et al. CHEMISTRY & BIOLOGY
- Clinical Studies of Histone Deacetylase Inhibitors
- (2009) H. M. Prince et al. CLINICAL CANCER RESEARCH
- Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks
- (2008) Sarah K Knutson et al. EMBO JOURNAL
- Pimelic Diphenylamide 106 Is a Slow, Tight-binding Inhibitor of Class I Histone Deacetylases
- (2008) C. James Chou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Deletion of Histone Deacetylase 3 Reveals Critical Roles in S Phase Progression and DNA Damage Control
- (2008) Srividya Bhaskara et al. MOLECULAR CELL
- Analysis of re-replication from deregulated origin licensing by DNA fiber spreading
- (2008) Elizabeth S. Dorn et al. NUCLEIC ACIDS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More